Senior Scientist, Lipid Lab - Human Nutrition Research Center, Tufts Medical Center
Endocrinology
Dr. Ernst J. Schaefer, MD
|
|
Give Review
Ernst Schaefer is an expert in the field of Endocrinology. He went to Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai has a rank of 20 in research and a 62 in primary care He received 1 awards: "Elected Member". Ernst Schaefer is also published. He has 99 publications published. The lastest publication: "Fenofibrate, HDL, and cardiovascular disease in Type-2 diabetes: The DAIS trial.'
Publications
- Fenofibrate, HDL, and cardiovascular disease in Type-2 diabetes: The DAIS trial.
- Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus.
- Effects of carbohydrate quantity and glycemic index on resting metabolic rate and body composition during weight loss.
- Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner.
- Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function.
- A novel ApoA-I truncation (ApoA-IMytilene) associated with decreased ApoA-I production.
- High-density lipoprotein metabolism, composition, function, and deficiency.
- Editorial introduction.
- The composition and metabolism of large and small LDL.
- The influence of apoE-deficiency and LDL-receptor-deficiency on the HDL subpopulation profile in mice and in humans.
- The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
- Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk?
- Linkage between C-reactive protein and triglyceride-rich lipoprotein metabolism.
- HDL deficiency due to a new insertion mutation (ApoA-I(Nashua)) and review of the literature.
- Effects of atorvastatin on human C-reactive protein metabolism.
- A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease.
- Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
- Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism.
- Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease: Results From the Framingham Heart Study.
- Apolipoprotein B-100-Containing Lipoprotein Metabolism in Subjects With Lipoprotein Lipase Gene Mutations.
- Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature.
- Measuring HDL: The Effect of Current HDL-Raising Therapies on HDL Levels and Subfractions.
- Adiponectin: An independent risk factor for coronary heart disease in men in the Framingham offspring Study.
- The effect of 17{beta}-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu.
- Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study.
- Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions.
- Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham ...
- Dietary intakes of arachidonic acid and alpha-linolenic acid are associated with reduced risk of hip fracture in older adults.
- Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.
- Limitations of Direct Methods and the Reference Method for Measuring HDL and LDL Cholesterol.
- HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events.
- Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation.
- Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellit...
- Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.
- Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women.
- Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study.
- Northern light: a commentary on the 2009 Canadian Guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in adults.
- Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.
- Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.
- HDL as a treatment target.
- Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects.
- Limitations of automated remnant lipoprotein cholesterol assay for diagnostic use.
- Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD.
- Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.
- Dietary fructose and glucose differentially affect lipid and glucose homeostasis.
- Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.
- Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.
- Serum lipid and antioxidant responses in hypercholesterolemic men and women receiving plant sterol esters vary by apolipoprotein E genotype.
- Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women.
- Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.
- Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein-deficiency states.
- Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.
- Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.
- Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women.
- Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency.
- Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.
- Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Interv...
- Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction.
- Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
- Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism.
- Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?
- Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women.
- Hypertriglyceridemia and cardiovascular risk reduction.
- Role of LCAT in HDL remodeling: investigation of LCAT deficiency states.
- Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
- Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
- Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.
- Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects.
- Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
- Potential role of dietary n-3 fatty acids in the prevention of dementia and macular degeneration.
- Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affai...
- Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women.
- Low-carbohydrate or low-fat diets for the metabolic syndrome?
- Low-fat diets and weight change.
- Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study.
- The effects of statins on high-density lipoproteins.
- Pharmacogenomics of statin responsiveness.
- The effects of low-fat, high-carbohydrate diets on plasma lipoproteins, weight loss, and heart disease risk reduction.
- Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux.
- Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.
- Differences in serum sex hormone and plasma lipid levels in Caucasian and African-American premenopausal women.
- TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
- Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.
- Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart...
- The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.
- Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial.
- High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study.
- Gender-specific association of a perilipin gene haplotype with obesity risk in a white population.
- Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial.
- Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome.
- Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
- Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
- Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses.
- Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.
- Fish consumption shifts lipoprotein subfractions to a less atherogenic pattern in humans.
- Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
- Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner.
- Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.
Schools
Mount Sinai School Of Medicine Of New York University
Mt Sinai Hospital
National Institute Of Health
Doctors Specialties
- Internal Medicine
- Endocrinology
Accepted Insurances
Awards
- Elected Member
Education
-
Mount Sinai School of Medicine -
Icahn School of Medicine at Mount Sinai
Helpful Reviews
Similar Doctors
|
|
Dr. Joseph A. Majzoub, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Isaac S. Kohane, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George L. King, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin J. Abrahamson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert G. Dluhy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Corinne M. Rhodes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy J. Poterucha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Becker, MD |
|
|
Dr. Harpaul S. Sandhu, MD |